Konar Shameek 4
4 · Comera Life Sciences Holdings, Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Konar Shameek
Other
Transactions
- Purchase
12.0% Senior Secured Convertible Notes
2023-12-29$112500.00/sh(indirect: By Regolith Capital Investments L.P.)Exercise: $0.06From: 2023-12-29Exp: 2024-12-29→ Common Stock (2,045,454 underlying) - Purchase
Warrants to Purchase Common Stock
2023-12-29+4,090,908→ 4,090,908 total(indirect: By Regolith Capital Investments L.P.)Exercise: $0.06From: 2023-12-29Exp: 2028-12-29→ Common Stock (4,090,908 underlying)
Footnotes (2)
- [F1]Regolith Capital Investments, L.P. ("Regolith") entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which Regolith acquired (i) $112,500 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the "Notes") and (ii) 4,090,908 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share ("Common Stock"), at an exercise price of $0.055 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof.
- [F2]The reporting persons are general partners of Regolith and disclaim beneficial ownership of the securities held by Regolith except to the extent of their pecuniary interest therein